Related Experiment Videos
Oncogenes and growth factors
1St. Joseph's Hospital Community Cancer Center, Tampa, Florida.
Critical Reviews in Immunology
|January 1, 1988
Summary
Protooncogenes and oncogenes regulate cell growth. Aberrant activation leads to uncontrolled cell proliferation and malignant transformation, offering targets for novel cancer therapies.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Cellular functions like mitosis and differentiation are regulated by polypeptide gene products conserved across evolution.
- Growth factors stimulate cells expressing specific receptors, leading to autocrine growth when a cell produces both.
- Dysregulation of these genes, through constant activation or amplification, results in excessive growth factor production and continuous cellular response.
Purpose of the Study:
- To explore the role of protooncogenes and oncogenes in cell growth and malignant transformation.
- To investigate the mechanisms by which gene dysregulation leads to uncontrolled cell proliferation.
- To identify potential therapeutic strategies targeting aberrant growth factor signaling in cancer.
Main Methods:
- Analysis of gene regulation, including permanent activation and amplification of growth factor and receptor genes.
- Investigation of mutated receptor genes leading to a permanently activated state.
- Examination of retroviral oncogenes (v-onc) derived from cellular protooncogenes (c-onc).
Main Results:
- Permanently activated or mutated receptor genes yield truncated receptors, causing continuous cell signaling.
- Protooncogene-oncogene activation is linked to cell immortalization and malignant transformation.
- Non-transforming growth factors can also stimulate cell growth, mimicking protooncogene effects.
Conclusions:
- Targeting excessive growth factors or receptors with monoclonal antibodies can disrupt autocrine/paracrine signaling.
- Biological response modifiers offer a potential therapeutic approach to deactivate protooncogenes-oncogenes.
- Interventions targeting these pathways may lead to novel treatments for malignant processes.